Access

News


Nature Medicine 14, 795 (2008)
doi:10.1038/nm0808-795b

National Cancer Institute helps businesses cross 'the valley of death'

Prashant Nair1

  1. Boston

The San Diego–based biotechnology firm NovaRx develops new cancer therapeutics, including experimental approaches involving vaccines. Like many other small companies, NovaRx faces a funding hurdle in advancing drugs from its pipeline into human clinical trials, says executive vice-chairman Habib Fakhrai.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Human therapeutic proteins from silkworms

Nature Biotechnology Research News (01 Jan 2003)

$rb.Type.Code